UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059023
Receipt number R000067501
Scientific Title Retrospective Analysis of Surgical Treatment of Lymphedema
Date of disclosure of the study information 2025/09/07
Last modified on 2025/09/07 08:57:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective Analysis of Surgical Treatment of Lymphedema

Acronym

Retrospective Analysis of Surgical Treatment of Lymphedema

Scientific Title

Retrospective Analysis of Surgical Treatment of Lymphedema

Scientific Title:Acronym

Retrospective Analysis of Surgical Treatment of Lymphedema

Region

Japan


Condition

Condition

Lymphedema

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to collect and analyze postoperative data on lymphedema patients.

Basic objectives2

Others

Basic objectives -Others

Exploration

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between Surgical Procedure and Postoperative Circumference

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients diagnosed with lymphedema who underwent surgical treatment for lymphedema.
2. Patients diagnosed with lymphedema who declined surgical treatment and are currently under observation.

Key exclusion criteria

1. Cases where the subject or their authorized representative expressed refusal to participate in this study
2. Other cases deemed unsuitable as research subjects by the responsible investigator

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Kazuo
Middle name
Last name Kishi

Organization

Keio University School of Medicine

Division name

Department of Plastic and Reconstructive surgery

Zip code

1608582

Address

Shinanomachi 35 Shinjuku

TEL

0353633814

Email

kkishi@keio.jp


Public contact

Name of contact person

1st name Yushi
Middle name
Last name Suzuki

Organization

Keio University School of Medicine

Division name

Department of Plastic and Reconstructive surgery

Zip code

1608582

Address

Shinanomachi 35 Shinjuku

TEL

0353633814

Homepage URL


Email

fi080150@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name

Kazuo Kishi


Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

Shinanomachi 35

Tel

0353633814

Email

fi080150@keio.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

東京都


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 06 Month 27 Day

Date of IRB

2022 Year 06 Month 27 Day

Anticipated trial start date

2022 Year 06 Month 27 Day

Last follow-up date

2032 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study includes patients who underwent surgical treatment for lymphedema. For these patients, we will compare the surgical site, number of procedures performed, surgical technique, postoperative circumference and firmness, incidence of cellulitis, changes in fluid volume, and changes in subjective symptoms.
Additionally, for patients who underwent surgery prior to the study approval date and for whom these data have already been collected, consent will be obtained via an opt-out approach.


Management information

Registered date

2025 Year 09 Month 07 Day

Last modified on

2025 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067501